Literature DB >> 29302672

Synthesis of spiro-tetrahydrothiopyran-oxindoles by Michael-aldol cascade reactions: discovery of potential P53-MDM2 inhibitors with good antitumor activity.

Shengzheng Wang1, Shuqiang Chen, Zhongjie Guo, Shipeng He, Fan Zhang, Xueying Liu, Weiping Chen, Shengyong Zhang, Chunquan Sheng.   

Abstract

Using proline as the catalyst, an organocatalytic Michael-aldol cascade reaction was developed for the synthesis of spiro-tetrahydrothiopyran oxindoles. The highly functionalized scaffold was assembled in moderate to good yields (51-78%) and excellent diastereoselectivities (>20 : 1 dr). Interestingly, the oxindoles displayed moderate to good in vitro antitumor activities and were validated as p53-MDM2 inhibitors, which represented promising lead compounds for antitumor drug discovery.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29302672     DOI: 10.1039/c7ob02726e

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  3 in total

1.  Discovery of novel KRAS‒PDEδ inhibitors with potent activity in patient-derived human pancreatic tumor xenograft models.

Authors:  Long Chen; Jing Zhang; Xinjing Wang; Yu Li; Lu Zhou; Xiongxiong Lu; Guoqiang Dong; Chunquan Sheng
Journal:  Acta Pharm Sin B       Date:  2021-07-19       Impact factor: 11.413

2.  Facile one-pot, multi-component reaction to synthesize spirooxindole-annulated thiopyran derivatives under environmentally benevolent conditions.

Authors:  F Matloubi Moghaddam; Bagher Aghamiri
Journal:  Heliyon       Date:  2022-09-20

3.  Targeted Synthesis of Complex Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-ones by Intramolecular Cyclization of Azomethine Ylides: Highly Potent MDM2-p53 Inhibitors.

Authors:  Andreas Gollner; Harald Weinstabl; Julian E Fuchs; Dorothea Rudolph; Geraldine Garavel; Karin S Hofbauer; Jale Karolyi-Oezguer; Gerhard Gmaschitz; Wolfgang Hela; Nina Kerres; Elisabeth Grondal; Patrick Werni; Juergen Ramharter; Joachim Broeker; Darryl B McConnell
Journal:  ChemMedChem       Date:  2018-12-11       Impact factor: 3.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.